HR 3605
98th Congress
House
Health
Administrative procedure
Consumer protection
DNA
Deceptive advertising
Drug industry
Drug safety and regulation
Drugs and narcotics
Generic drugs
Import restrictions
Injunctions
Labeling laws
Patents
Pharmaceutical research
Textile industry and fabrics
Wool
Drug Price Competition and Patent Term Restoration Act of 1984
Introduced: July 19, 1983
See on congress.gov
Everywhere this bill has been
30 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Sep 6, 1984
Committee Amendment in the Nature of a Substitute Considered as an Original Bill for the Purpose of Amendment.
Sep 6, 1984
House Incorporated this Measure (Amended) in S.1538 as an Amendment.
Sep 6, 1984
Laid on Table in House by Voice Vote.
Sep 6, 1984
Passed House (Amended) by Yea-Nay Vote: 362 - 0 (Record Vote No: 379).
Sep 6, 1984
Passed/agreed to in House: Passed House (Amended) by Yea-Nay Vote: 362 - 0 (Record Vote No: 379).
Sep 6, 1984
House Agreed to Amendments Adopted by the Committee of the Whole.
Sep 6, 1984
The Clerk Reported Committee Amendments.
Aug 8, 1984
Called up by House by Rule.
Aug 8, 1984
Rules Committee Resolution H.Res.569 Reported to House.
Aug 8, 1984
Committee on Rules Granted an Open Rule Providing Two Hours of General Debate; Making in Order the Energy and Commerce Committee Amendment in the Nature of a Substitute now Printed in the Bill as Original Text for the Purposes of Amendment; Waiving all Points of Order Against the Amendment for Failure to Comply with the Provisions of Clause 7, Rule XVI.
Aug 8, 1984
Considered by House Unfinished Business.
Aug 8, 1984
Rule Passed House.
Aug 1, 1984
Reported to House (Amended) by House Committee on The Judiciary. Report No: 98-857 (Part II).
Aug 1, 1984
Placed on Union Calendar No: 531.
Jul 31, 1984
Committee Consideration and Mark-up Session Held.
Jul 31, 1984
Ordered to be Reported (Amended).
Jul 25, 1984
Forwarded by Subcommittee to Full Committee (Amended).
Jul 25, 1984
Subcommittee Consideration and Mark-up Session Held.
Jun 27, 1984
Subcommittee Hearings Held.
Jun 25, 1984
Referred to Subcommittee on Courts, Civil Liberties, and the Administration of Justice.
Jun 21, 1984
Referred to House Committee on The Judiciary Sequentially, for a Period Ending not Later than Aug 1, 84.
Jun 21, 1984
Reported to House (Amended) by House Committee on Energy and Commerce. Report No: 98-857 (Part I).
Jun 12, 1984
Ordered to be Reported (Amended) by Voice Vote.
Jun 12, 1984
Committee Consideration and Mark-up Session Held.
Aug 2, 1983
Forwarded by Subcommittee to Full Committee.
Aug 2, 1983
Subcommittee Consideration and Mark-up Session Held.
Jul 25, 1983
Subcommittee Hearings Held.
Jul 21, 1983
Referred to Subcommittee on Health and the Environment.
Jul 19, 1983
Referred to House Committee on Energy and Commerce.
Jul 19, 1983
Introduced in House
Plain-English summary
Drug Price Competition Act of 1983 - Amends the Federal Food, Drug, and Cosmetic Act to exempt from Food and Drug Administration (FDA) clinical application requirements new drugs that are the same as previously approved new drugs (extends FDA abbreviated drug application procedures to post-1962 new generic drugs).
What's happening now
House Incorporated this Measure (Amended) in S.1538 as an Amendment.